Disease/Infection News

RSS

Researchers report functional and transferable gene responsible for colistin resistance

A researcher at LSTM, working with a team of Chinese investigators, have reported that the gene responsible for resistance to a last resort antibiotic, colistin, is functional and transferable in Shigella flexneri, one of the leading causes of diarrhea worldwide.

2 Mar 2018

Scientists evaluate reliability of Zika virus diagnostics

Globally, Brazil has been the hardest hit by the current Zika outbreak. Almost all cases of Zika-associated malformations in newborns have been reported from this country

2 Mar 2018

Extra sunlight in late summer could help reduce severity of flu season

People getting more rays of sunlight - and therefore vitamin D - in August and September could help reduce the severity of flu season, according to a National Bureau of Economic Research working paper co-authored by a University of Kansas economist.

2 Mar 2018

Skin bacteria may be an answer to cancer find researchers

The skin protects the body from harm and is also covered with billions of bacteria which are called commensal bacteria that form the microbiota of the skin. These are friendly bacteria that stay on the skin surface without causing harm.

2 Mar 2018

Fraunhofer researchers develop process to accurately diagnose koi herpes virus

Whether grilled, spicy with bell peppers or breaded in flour and fried floating in oil - the carp is one of the most popular edible fish.

1 Mar 2018

Fraunhofer researchers pursue gentle approach to treat microbial keratitis

Microbial infections of the cornea can have serious consequences, including blindness in the worst case. The treatment of keratitis, a condition caused by certain pathogens, always presents major challenges to ophthalmologists.

1 Mar 2018

Reduced risk of heart disease for mothers who breastfeed

According to a new study, women who breastfeed their babies for a minimum of 6 months after giving birth have a reduced risk of heart disease in later life.

1 Mar 2018

Getting influenza vaccine linked to 50% drop in risk of death for heart failure patients

For people with heart failure, getting a seasonal influenza (flu) vaccine in a given year was associated with a 50 percent drop in the risk of death during flu season and a 20 percent drop in the risk of death during the rest of the year, according to research presented at the American College of Cardiology's 67th Annual Scientific Session.

1 Mar 2018

Scientists identify single genetic change in Salmonella that plays key role in bloodstream infections

Scientists have identified a single genetic change in Salmonella that is playing a key role in the devastating epidemic of bloodstream infections currently killing around 400,000 people each year in sub-Saharan Africa.

1 Mar 2018

At some California hospitals, fewer than half of workers get the flu shot

How well are doctors, nurses and other workers at your local hospital vaccinated against the flu?

28 Feb 2018

NIAID details new strategic plan for creating safe, effective universal influenza vaccine

Developing a universal influenza vaccine -- a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic -- is a priority for the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

28 Feb 2018

Obesity not found to be risk factor for acute respiratory illnesses

Although obesity has been considered a risk factor for more-severe cases of the flu, a new study found that it is not a risk factor for severe acute respiratory illnesses, including the flu, in children or adults.

28 Feb 2018

Bacteria in humans and animals continue to show high levels of antimicrobial resistance

Bacteria from humans and animals continue to show resistance to antimicrobials, according to a new report published today by the European Food Safety Authority and the European Centre for Disease Prevention and Control.

28 Feb 2018

ICU risk scores can be repurposed as continuous markers of illness severity

Commonly used ICU risk scores can be "repurposed" as continuous markers of severity of illness in critically ill patients--providing ongoing updates on changes in the patient's condition and risk of death, according to a study in the March issue of Critical Care Medicine, official journal of the Society of Critical Care Medicine. The journal is published by Wolters Kluwer.

27 Feb 2018

Researchers create models that predict spread of flu in the United States

Using several large datasets describing health care visits, geographic movements and demographics of more than 150 million people over nine years, researchers at the University of Chicago have created models that predict the spread of influenza throughout the United States each year.

27 Feb 2018

Australian brings measles to New York sparking fears for unvaccinated

According to the city officials in New York, the small population of unvaccinated individuals need to be extra careful over the next couple of weeks because an Australian individual with suspected measles has arrived in the city. This announcement was made last Friday by the New York State Department of Health.

26 Feb 2018

Demographic characteristics can help identify immigrants at high risk of TB in Canada

Demographic characteristics can help identify groups of immigrants in Canada at high risk of tuberculosis, according to new research in CMAJ.

26 Feb 2018

Steps to take for boosting immune system and maintaining a healthy body

We know that germs can make you sick, but if you seem to constantly be under the weather with cold symptoms, could it be something other than germs that are getting you down?

24 Feb 2018

Researchers developing rapid saliva test to detect Zika virus

Researchers at New York University College of Dentistry, in collaboration with Rheonix, Inc., are developing a novel test for Zika virus that uses saliva to identify diagnostic markers of the virus in a fraction of the time of current commercial tests.

24 Feb 2018

U.S. clinical sites evaluating antibody-based therapies to prevent two common bacterial infections

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is supporting U.S. clinical sites participating in two ongoing international Phase 2 clinical trials evaluating investigational antibody-based therapies aimed at preventing potentially antibiotic-resistant infections.

23 Feb 2018